NeoGenomics (NEO) News Today $16.41 +0.01 (+0.06%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period NEO Battery Materials and Specialty Automotive Battery Cell Manufacturer Sign Joint Development Agreement for Silicon-Enhanced Battery TechnologyDecember 19 at 10:01 AM | globenewswire.comFranklin Resources Inc. Raises Stake in NeoGenomics, Inc. (NASDAQ:NEO)Franklin Resources Inc. boosted its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 2.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,043,840 shares of the medical research company's stock after buyingDecember 19 at 5:33 AM | marketbeat.comState Street Corp Has $73.14 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)State Street Corp increased its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 1.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,958,582 shares of the medical research company's stock aDecember 18 at 3:35 AM | marketbeat.comNeoGenomics Shows Rising Relative Strength; Still Shy Of Key ThresholdDecember 17, 2024 | msn.comNeoGenomics (NASDAQ:NEO) Stock Price Expected to Rise, Bank of America Analyst SaysDecember 16, 2024 | americanbankingnews.comNeoGenomics price target raised to $19 from $18 at BofADecember 14, 2024 | markets.businessinsider.comBank of America Raises NeoGenomics (NASDAQ:NEO) Price Target to $19.00Bank of America lifted their price objective on shares of NeoGenomics from $18.00 to $19.00 and gave the company a "neutral" rating in a research report on Friday.December 13, 2024 | marketbeat.comJefferies Initiates Coverage of NeoGenomics (NEO) with Buy RecommendationDecember 11, 2024 | msn.comNeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk MelanomaDecember 11, 2024 | finance.yahoo.comBNP Paribas Financial Markets Has $1.08 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO)BNP Paribas Financial Markets lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 110.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,963 shares of the medical research company'December 11, 2024 | marketbeat.comNeoGenomics initiated with a Buy at JefferiesDecember 10, 2024 | markets.businessinsider.comNeoGenomics Getting Closer To Key Technical MeasureDecember 10, 2024 | msn.comNeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual MeetingDecember 9, 2024 | businesswire.comCharles Schwab Investment Management Inc. Acquires 57,677 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Charles Schwab Investment Management Inc. boosted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 5.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,134,651 shares ofDecember 8, 2024 | marketbeat.comEdgestream Partners L.P. Sells 94,791 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Edgestream Partners L.P. cut its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 73.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 34,798 shares of the medical research company's sDecember 6, 2024 | marketbeat.comConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical ResearchDecember 5, 2024 | businesswire.comNEO Battery Materials Confirms Stable and Unaffected Operations Amid South Korea's Declaration of Emergency Martial LawDecember 3, 2024 | globenewswire.comBellevue Group AG Buys 410,516 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Bellevue Group AG lifted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 34.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,612,612 shares of the medical researcDecember 1, 2024 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of "Buy" by AnalystsNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has earned an average recommendation of "Buy" from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have isNovember 30, 2024 | marketbeat.comAlgert Global LLC Boosts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Algert Global LLC raised its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 204.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,983 shares of the medical research company's stock afNovember 29, 2024 | marketbeat.comLoomis Sayles & Co. L P Invests $17.81 Million in NeoGenomics, Inc. (NASDAQ:NEO)Loomis Sayles & Co. L P acquired a new stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,207,290 shares of the medical research company's stockNovember 27, 2024 | marketbeat.comNEO Battery Materials Announces Corporate Webinar on Silicon Anode Technology Developments & Pathway to CommercializationNovember 25, 2024 | globenewswire.comJennison Associates LLC Acquires 57,041 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Jennison Associates LLC increased its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 4.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,276,468 shares ofNovember 23, 2024 | marketbeat.comSegall Bryant & Hamill LLC Has $27.93 Million Stake in NeoGenomics, Inc. (NASDAQ:NEO)Segall Bryant & Hamill LLC increased its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 67.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,893,407 shares of the medical research company's stock afterNovember 20, 2024 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) General Counsel Alicia C. Olivo Sells 5,175 SharesNovember 20, 2024 | insidertrades.comNeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized TreatmentNovember 19, 2024 | finance.yahoo.comLos Angeles Capital Management LLC Acquires New Stake in NeoGenomics, Inc. (NASDAQ:NEO)Los Angeles Capital Management LLC bought a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 74,633 shares of the medical research company's stock, valued atNovember 15, 2024 | marketbeat.comNeoGenomics: Strong Growth Potential in Oncology Lab Testing Justifies Buy RatingNovember 8, 2024 | markets.businessinsider.comNeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 8, 2024 | finance.yahoo.comNeoGenomics Reports Strong Q3 2024 GrowthNovember 6, 2024 | markets.businessinsider.comNeoGenomics: Balancing Growth in NGS with ADx Challenges Amid Strategic ProgressNovember 6, 2024 | markets.businessinsider.comNeoGenomics' (NEO) "Buy" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $19.00 target price on shares of NeoGenomics in a research note on Wednesday.November 6, 2024 | marketbeat.comQ3 2024 Neogenomics Inc Earnings CallNovember 6, 2024 | finance.yahoo.comNeoGenomics Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 6, 2024 | finance.yahoo.comNeoGenomics Reports Third Quarter 2024 ResultsNovember 5, 2024 | finanznachrichten.deTwo SW FL companies report earnings on Election Day. Here's a look at how they performedNovember 5, 2024 | msn.comNeoGenomics’ Strong Q3 Performance and Growth Potential Drive Buy RecommendationNovember 5, 2024 | markets.businessinsider.comNeoGenomics’ Strong Financial Performance and Growth Potential Earns Buy RatingNovember 5, 2024 | markets.businessinsider.comNeoGenomics, Inc. (NEO) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comNeoGenomics, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 5, 2024 | seekingalpha.comNeoGenomics (NASDAQ:NEO) Updates FY 2024 Earnings GuidanceNeoGenomics (NASDAQ:NEO) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.080-0.100 for the period, compared to the consensus estimate of 0.060. The company also issued revenue guidance of $655.0 millionillion-$667.0 millionillion, compared to the consensus estimate of $661.7 millionillion.November 5, 2024 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have received an average recommendation of "Moderate Buy" from the ten ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating on tNovember 5, 2024 | marketbeat.comEmerald Advisers LLC Cuts Position in NeoGenomics, Inc. (NASDAQ:NEO)Emerald Advisers LLC trimmed its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 8.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,682,214 shares of theNovember 3, 2024 | marketbeat.comNeoGenomics (NEO) to Release Earnings on TuesdayNeoGenomics (NASDAQ:NEO) will be releasing earnings before the market opens on Tuesday, November 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635831)October 29, 2024 | marketbeat.comNeoGenomics gains conditional approval for solid tumour assays in New YorkOctober 23, 2024 | msn.comNeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor TestOctober 22, 2024 | finance.yahoo.comNeoGenomics (NASDAQ:NEO) Shares Down 2.5% - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Down 2.5% - Time to Sell?October 16, 2024 | marketbeat.comRenaissance Technologies LLC Cuts Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Renaissance Technologies LLC cut its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 89.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,300 shares of the medOctober 13, 2024 | marketbeat.comNeoGenomics Unveils AML ExpressOctober 8, 2024 | baystreet.caNeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid LeukemiaOctober 8, 2024 | finance.yahoo.com Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Your chance to get on the next “60-Second Trade” (Ad)Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday! Just head over here! NEO Media Mentions By Week NEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼0.920.60▲Average Medical News Sentiment NEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼54▲NEO Articles Average Week Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HealthEquity News MARA News Bilibili News Etsy News QXO News Lyft News Nuvei News TriNet Group News CarGurus News DXC Technology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEO Stock Alerts